Old Web
English
Sign In
Acemap
>
Paper
>
SGLT2 inhibitors: further evidence for heart failure with preserved ejection fraction as a metabolic disease?
SGLT2 inhibitors: further evidence for heart failure with preserved ejection fraction as a metabolic disease?
2021
Justin B. Echouffo-Tcheugui
Sabra C. Lewsey
Robert G. Weiss
Keywords:
Cardiology
Heart failure with preserved ejection fraction
metabolic disease
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
21
References
0
Citations
NaN
KQI
[]